Home Search

OXIS - search results

If you're not happy with the results, please do another search
marijuana stocks news

GT Biopharma Inc. (OXISD) Announces Reverse Stock Spilt As Part of Planned Merger

GT Biopharma, Inc. Announces Reverse Stock Spilt As Part of Oxis-Georgetown Planned Merger GT Biopharma Inc. (formerly known as Oxis International, Inc.) announced today a...
marijuana_stocks_conference_call

GT Biopharma (OXIS) Conf Call Reminder

GT Biopharma (OXIS) Conf. Call Today GT Biopharma (OXIS) made another move higher on Today (8-16) to highs of $0.123. This marks a total run...
marijuana stocks news

GT Biopharma Inc. (OXIS) Executives to Present at Rodman & Renshaw Conference in New...

GT Biopharma (OXIS) Executives to Present at Rodman & Renshaw Conference in New York  GT Biopharma Inc. (OTCQB:OXIS and Euronext Paris OXI.PA) announced today that...
marijuana stocks chart

Re-Cap & Update on GT Biopharma (OXIS)

For the last week, we’ve been covering a company that has seen a huge bump in attention and trading momentum.  GT Biopharma (OXIS) could be...
marijuana stocks news

GT Biopharma Inc. (OXIS) Announces Corporate Update Conference Call

GT Biopharma, Inc. (Oxis) Announces Corporate Update Conference Call With Incoming CEO Dr. Kathleen Clarence-Smith and Chairman Anthony Cataldo GT Biopharma Inc. (OTCQB:OXIS and Euronext...
marijuana stocks news

GT Biopharma Inc. (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial

GT Biopharma (OXIS) Announces Enrollment of Fourth Patient in FDA Phase 2 Trial of Cancer Drug OXS-1550  GT Biopharma Inc. (OTCQB: OXIS) and Euronext Paris...
marijuana stocks news

$OXIS Adds New Patients in Phase 1/Phase 2 Clinical Trials

Oxis Adds New Patients in Phase 1/Phase 2 Clinical Trial of Key Cancer Drug OXS-1550  Oxis International Inc. (OTC:OXIS and OXI.PA), a biotechnology company focused...
marijuana stocks

$OXIS Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical Trial

Oxis Begins Enrolling and Treating Patients in FDA Phase 1/Phase 2 Clinical Trial of Key Cancer Drug OXS-1550 Oxis International, Inc. (OTCQB: OXIS and Euronext...
marijuana stocks news

$OXIS Announces Key U.S. Patent Issued for Its Cancer Drug, OXS-1550

OXIS Biotech Announces Key U.S. Patent Issued for Its Cancer Drug, OXS-1550 Oxis Biotech Inc., a wholly owned subsidiary of Oxis International, Inc. (OTCQB: OXIS...
marijuana stocks news

$OXIS Dr. Daniel Vallera to the Scientific Advisory Board

Oxis Biotech Announces University of Minnesota's Dr. Daniel Vallera to the Scientific Advisory Board Oxis International Inc. (OTCQB: OXIS and Euronext Paris: OXI.PA), a biotechnology...

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com